207 related articles for article (PubMed ID: 16706826)
21. Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C.
Aoki CA; Rossaro L; Ramsamooj R; Brandhagen D; Burritt MF; Bowlus CL
J Clin Gastroenterol; 2005 Jan; 39(1):71-4. PubMed ID: 15599216
[TBL] [Abstract][Full Text] [Related]
22. State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin.
Jurczyk K; Karpińska E; Wawrzynowicz-Syczewska M; Morańska I; Noceń I; Chlubek D; Boroń-Kaczmarska A
Hepatogastroenterology; 2008; 55(82-83):557-61. PubMed ID: 18613407
[TBL] [Abstract][Full Text] [Related]
23. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
24. Changes of hepatic vitronectin levels in patients with chronic hepatitis C treated with interferon alpha.
Yamada S; Suou T; Kawasaki H; Horie Y; Nagami M; Yashima S; Sugihara C; Tanaka H
Res Commun Mol Pathol Pharmacol; 1999; 104(3):253-63. PubMed ID: 10741376
[TBL] [Abstract][Full Text] [Related]
25. Expression of thioredoxin and thioredoxin-binding protein-2 in the liver of patients with chronic hepatitis C as a predictor of response to interferon therapy.
Hamano K; Seo Y; Kato H; Kato M; Yano Y; Ninomiya T; Kasuga M
Int J Mol Med; 2006 Jun; 17(6):989-95. PubMed ID: 16685406
[TBL] [Abstract][Full Text] [Related]
26. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
[TBL] [Abstract][Full Text] [Related]
27. [Expression of IFN-alpha/beta receptor in the PBMCs and liver of patients with hepatitis B and its clinical significance].
Fan HB; Guo YB; Wang BJ; Zhu YF; Wu AH; Hou JL; Yang DL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):979-81. PubMed ID: 18583243
[TBL] [Abstract][Full Text] [Related]
28. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells.
Lee AW; Oates PS; Trinder D
Hepatology; 2003 Oct; 38(4):967-77. PubMed ID: 14512884
[TBL] [Abstract][Full Text] [Related]
29. Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat.
Pascale RM; De Miglio MR; Muroni MR; Simile MM; Daino L; Seddaiu MA; Pusceddu S; Gaspa L; Calvisi D; Manenti G; Feo F
Hepatology; 1998 Feb; 27(2):452-61. PubMed ID: 9462644
[TBL] [Abstract][Full Text] [Related]
30. Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study.
Alexander J; Tung BY; Croghan A; Kowdley KV
Liver Int; 2007 Mar; 27(2):268-73. PubMed ID: 17311623
[TBL] [Abstract][Full Text] [Related]
31. Transferrin receptor 2 is frequently expressed in human cancer cell lines.
Calzolari A; Oliviero I; Deaglio S; Mariani G; Biffoni M; Sposi NM; Malavasi F; Peschle C; Testa U
Blood Cells Mol Dis; 2007; 39(1):82-91. PubMed ID: 17428703
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
[TBL] [Abstract][Full Text] [Related]
33. Progenitor cell activation in chronic viralhepatitis.
Fotiadu A; Tzioufa V; Vrettou E; Koufogiannis D; Papadimitriou CS; Hytiroglou P
Liver Int; 2004 Jun; 24(3):268-74. PubMed ID: 15189279
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription.
Nishina S; Hino K; Korenaga M; Vecchi C; Pietrangelo A; Mizukami Y; Furutani T; Sakai A; Okuda M; Hidaka I; Okita K; Sakaida I
Gastroenterology; 2008 Jan; 134(1):226-38. PubMed ID: 18166355
[TBL] [Abstract][Full Text] [Related]
35. Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients.
Kobayashi S; Takeda T; Enomoto M; Tamori A; Kawada N; Habu D; Sakaguchi H; Kuroda T; Kioka K; Kim SR; Kanno T; Ueda T; Hirano M; Fujimoto S; Jomura H; Nishiguchi S; Seki S
Liver Int; 2007 Mar; 27(2):186-91. PubMed ID: 17311612
[TBL] [Abstract][Full Text] [Related]
36. Associations between cellular immune effector function, iron metabolism, and disease activity in patients with chronic hepatitis C virus infection.
Weiss G; Umlauft F; Urbanek M; Herold M; Loyevsky M; Offner F; Gordeuk VR
J Infect Dis; 1999 Nov; 180(5):1452-8. PubMed ID: 10515803
[TBL] [Abstract][Full Text] [Related]
37. TfR2 expression in human colon carcinomas.
Calzolari A; Deaglio S; Maldi E; Cassoni P; Malavasi F; Testa U
Blood Cells Mol Dis; 2009; 43(3):243-9. PubMed ID: 19729324
[TBL] [Abstract][Full Text] [Related]
38. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C.
Carotti S; Morini S; Corradini SG; Burza MA; Molinaro A; Carpino G; Merli M; De Santis A; Muda AO; Rossi M; Attili AF; Gaudio E
Liver Transpl; 2008 Jun; 14(6):806-14. PubMed ID: 18508359
[TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase-2 expression in chronic hepatitis C and the effect of interferon alpha treatment.
Manning DS; Sheehan KM; Byrne MF; Kay EW; Murray FE
J Gastroenterol Hepatol; 2007 Oct; 22(10):1633-7. PubMed ID: 17845691
[TBL] [Abstract][Full Text] [Related]
40. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.
Kawaguchi T; Ide T; Taniguchi E; Hirano E; Itou M; Sumie S; Nagao Y; Yanagimoto C; Hanada S; Koga H; Sata M
Am J Gastroenterol; 2007 Mar; 102(3):570-6. PubMed ID: 17222321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
